Poor Adherence with Hypolipidemic Drugs: A Lost Opportunity
- 1 May 2001
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 21 (5) , 576-582
- https://doi.org/10.1592/phco.21.6.576.34541
Abstract
All articles assessing adherence to hypolipidemic drugs were reviewed and categorized by patient population (clinical trial, unselected) and reported as rates of nonadherence and discontinuation. Ove...Keywords
This publication has 25 references indexed in Scilit:
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Drug Compliance in Therapeutic Trials: A ReviewControlled Clinical Trials, 1998
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Persistence of Use of Lipid-Lowering MedicationsJAMA, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medicationsThe Lancet, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- The Financial Implications of Initial Noncompliance:Journal of Research in Pharmaceutical Economics, 1995
- Discontinuation of Antihyperlipidemic Drugs — Do Rates Reported in Clinical Trials Reflect Rates in Primary Care Settings?New England Journal of Medicine, 1995
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987